ClinicalTrials.gg
Enrolling by invitationNCT07645417Updated Sep 9, 2026

Maxillary Canine Retraction Using Stainless Steel and Titanium-molybdenum Alloy Wires in TAD-supported Segmental Mechanics

An interventional study of A titanium-molybdenum alloy reverse-closing loop and A stainless steel reverse closing loop in Malocclusion, Canine Retraction and Orthodontics, sponsored by Tanzila Rafique. Enrolling by invitation at 1 site in Bangladesh. Open to participants aged 15 Months to 35 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Tanzila Rafique · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jul 2025, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
15 Months to 35 Months
Sex
All
01

Study summary

The goal of this randomized clinical study is to compare the effectiveness of stainless steel (SS) and titanium-molybdenum alloy (TMA) wires for maxillary canine retraction using TAD-supported segmental mechanics. The main question it aims to answer is:

Which wire material, stainless steel or titanium-molybdenum alloy, provides better outcomes in maxillary canine retraction when used with TAD-supported segmental mechanics? Researchers will compare SS reverse-closing loops with TMA reverse-closing loops to evaluate differences in the rate of canine retraction and canine angulation changes during orthodontic space closure.

Participants will:

  • Receive mini-implants/TADs on both sides of the maxillary arch.
  • Receive a stainless steel reverse-closing loop on one side and a TMA reverse-closing loop on the contralateral side.
  • Receive the same standardized force of 150 g on both sides.
  • Visit the clinic every 4 weeks for a total duration of 4 months.
  • Undergo OPG radiographs before retraction and after the 4-month study period to assess canine angulation.
Read the detailed description

Background: Canine retraction is vital in orthodontic treatment, especially in first premolar extraction cases. Stainless steel (SS) and titanium-molybdenum alloy (TMA) wires are two most commonly used materials in segmental canine retraction with loop mechanics. Temporary anchorage devices (TADs), provide absolute anchorage.

Objective: To assess and compare maxillary canine retraction using SS and TMA wire in TAD-supported segmental mechanics.

Materials and Methods: After taking IRB approval, informed consent and assent a randomized clinical study will be conducted with 16 participants aged 15 to 35 years who require maxillary 1st premolar extraction on both sides to alleviate crowding or protrusion at Orthodontics department in Bangladesh Medical University (BMU). Each participant will receive a TAD on the same anatomic location with reverse closing loop (RCL) of SS wire 0.016 × 0.022" on one side and RCL of TMA wire 0.016 × 0.022" on contralateral side. Same 150 g force will be standardized with Dontrix gauge for both side. Rate of canine retraction will be measured intraorally with a digital slide caliper at four-week intervals for a total of four months. Canine angulation will be measured in OPG before retraction and after four months study period.

Statistical Analysis Plan: Data normality will be tested to select parametric or non-parametric analyses with P value \<0.05 as significant. All the analyses will be performed using SPSS (version 30.0, IBM, New York, USA).

Expected outcome: TMA wire other than SS wire may be more effective in maxillary canine retraction from TAD-supported segmental mechanics providing scientific rationale for material choice.

02

Conditions studied

  • Malocclusion
  • Canine Retraction
  • Orthodontics
  • Tooth Movement Techniques
  • Anchorage Planning

Browse trials for

Keywords

  • Maxillary canine retraction
  • Orthodontic anchorage
  • Segmental mechanics
  • Stainless steel wire
  • TMA wire
  • Reverse closing loop
  • TAD
  • Canine angulation
03

In context

Malocclusion

323 studies on the registry are indexed under Malocclusion; 85 are open to participants now.

This study's planned enrollment of 16 is below the median of 37 across 242 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Tanzila Rafique is the lead sponsor of 5 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Months to 35 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants aged 15 to 35 years.
  • Both male and female participants.
  • Patients with all permanent teeth present, excluding third molars.
  • Patients requiring extraction of both maxillary first premolars
  • Patients with Class I or Class II molar relationship requiring maximum anchorage.
  • Patients already undergoing fixed orthodontic treatment with a 0.018-inch Roth preadjusted appliance system.
  • Maxillary canines aligned, symmetrical, and upright before the study.
  • Patients in the leveling and alignment stage before canine retraction.

Exclusion criteria

Exclusion Criteria:

  • Missing or absent upper premolars.
  • Previous orthodontic, orthognathic or reconstructive treatment.
  • Systemic disease contraindicating dental implant placement.
  • Use of systemic drugs or presence of systemic illness.
  • Compromised periodontal condition.
  • Use of anti-inflammatory therapy.
  • Smokers.
  • Pregnant female participants.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Active comparator
    A titanium-molybdenum alloy reverse closing loop

    A titanium-molybdenum alloy reverse-closing loop will be placed on one side of the maxillary arch and activated with 150 g force for canine retraction.

    Procedure: A titanium-molybdenum alloy reverse-closing loop · Procedure: A stainless steel reverse closing loop

  • Active comparator
    A stainless steel reverse closing loop

    A stainless steel reverse-closing loop will be placed on the contralateral side of the maxillary arch and activated with the same 150 g force to retract the canine.

    Procedure: A titanium-molybdenum alloy reverse-closing loop · Procedure: A stainless steel reverse closing loop

Interventions

  • ProcedureA titanium-molybdenum alloy reverse-closing loop

    A titanium-molybdenum alloy reverse-closing loop will be placed on one side of the maxillary arch, and a stainless steel reverse-closing loop will be placed on the contralateral side of the maxillary arch and activated with a 150 g force to retract the canine.

  • ProcedureA stainless steel reverse closing loop

    A titanium-molybdenum alloy reverse-closing loop will be placed on one side of the maxillary arch, and a stainless steel reverse-closing loop will be placed on the contralateral side of the maxillary arch and activated with the same 150 g force for canine retraction.

06

What researchers measure

Primary outcomes

  1. Comparison of the rate of maxillary canine retraction using stainless steel and TMA reverse-closing loops in TAD-supported segmental mechanics over 4 months.

    The rate of maxillary canine retraction will be compared using stainless steel and TMA reverse-closing loops in TAD-supported segmental mechanics.

    Time frame: 4 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Confidentiality and privacy will be preserved by utilizing unique identifying codes instead of personal identifiers

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Aug 2026, 13 months.

Of 153 non-industry interventional studies with no phase under Malocclusion, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 30. This study's 13 months is below that.

Counting every sponsor, half of 163 studies reached it within 19 months; a quarter within 10 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2026
First posted
Jun 12, 2026
StartActual
Jul 1, 2025
Primary completionActual
Aug 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07645417
Lead sponsor
Tanzila Rafique
Responsible party
Tanzila Rafique (Associate Professor, Bangladesh Medical University) — Sponsor-investigator
First posted
Jun 12, 2026
Start date
Jul 1, 2025
Primary completion
Aug 1, 2026
Completion
Dec 1, 2026 (estimated)
Last update
Sep 9, 2026

Study contacts

Mahmood Sajedeen, BDS,FCPS
study director · Bangladesh Medical UNivbersity (BMU), Dhaka-1000

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion